Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1985 Jul;143(1):94.

Internal Medicine

New Antibiotics

Joseph Silva Jr
PMCID: PMC1306240  PMID: 18749800

Full text

PDF

Page 94

94

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eisenberg J. M., Koffer H., Finkler S. A. Economic analysis of a new drug: potential savings in hospital operating costs from the use of a once-daily regimen of a parenteral cephalosporin. Rev Infect Dis. 1984 Nov-Dec;6 (Suppl 4):S909–S923. doi: 10.1093/clinids/6.supplement_4.s909. [DOI] [PubMed] [Google Scholar]
  2. McCracken G. H., Jr, Threlkeld N., Mize S., Baker C. J., Kaplan S. L., Faingezicht I., Feldman W. E., Schaad U. Moxalactam therapy for neonatal meningitis due to gram-negative enteric bacilli. A prospective controlled evaluation. JAMA. 1984 Sep 21;252(11):1427–1432. [PubMed] [Google Scholar]
  3. Van Caekenberghe D. L., Pattyn S. R. In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives. Antimicrob Agents Chemother. 1984 Apr;25(4):518–521. doi: 10.1128/aac.25.4.518. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES